Transcatheter arterial chemoembolization with or without bevacizumab in hepatocellular carcinoma with portal vein invasion: a randomized trial
Abstract Objective To evaluate the efficacy and safety of transcatheter arterial chemoembolization (TACE) combined with bevacizumab arterial perfusion compared to TACE alone in patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombus (PVTT). Methods In this prospective, randomized...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BMC
2025-12-01
|
| Edice: | Cancer Imaging |
| Témata: | |
| On-line přístup: | https://doi.org/10.1186/s40644-025-00949-y |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
